
Regulatory submissions are a critical step in bringing new drugs and medical interventions to market, the success of which heavily relies on the quality and fitness of the data presented to the regulatory bodies.
Claude Price is the head of Clinical Data Management at Quanticate.

Published: March 15th 2024 | Updated: